Bicocca Open Archive

Logo unimib boa
CHIORAZZI, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.657
EU - Europa 6.497
AS - Asia 3.234
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 23
SA - Sud America 18
AF - Africa 12
Totale 21.480
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.448
IT - Italia 1.405
DE - Germania 1.242
CN - Cina 1.209
SG - Singapore 1.177
SE - Svezia 935
IE - Irlanda 813
RU - Federazione Russa 649
UA - Ucraina 521
GB - Regno Unito 311
HK - Hong Kong 310
CA - Canada 200
VN - Vietnam 194
AT - Austria 138
FI - Finlandia 137
DK - Danimarca 114
FR - Francia 106
IN - India 89
JP - Giappone 57
ID - Indonesia 56
TR - Turchia 47
BE - Belgio 39
KR - Corea 34
NL - Olanda 29
EU - Europa 23
AU - Australia 21
MY - Malesia 20
IR - Iran 18
NZ - Nuova Zelanda 18
ES - Italia 10
BR - Brasile 9
TW - Taiwan 9
PL - Polonia 8
EG - Egitto 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
HR - Croazia 6
HU - Ungheria 6
MX - Messico 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
CL - Cile 3
PT - Portogallo 3
RO - Romania 3
AR - Argentina 2
CO - Colombia 2
GT - Guatemala 2
LB - Libano 2
NG - Nigeria 2
RS - Serbia 2
SC - Seychelles 2
AL - Albania 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
NO - Norvegia 1
PE - Perù 1
PK - Pakistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 21.480
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.859
Singapore 974
Dublin 792
Woodbridge 773
Chandler 772
Frankfurt am Main 741
Wilmington 634
Houston 580
Fairfield 565
Dearborn 547
Jacksonville 539
Milan 519
Ashburn 452
New York 374
Santa Clara 323
Princeton 302
Hong Kong 274
Nanjing 232
Seattle 231
Boardman 179
Cambridge 161
Shanghai 148
Vienna 138
Beijing 99
Dong Ket 92
Guangzhou 86
Lachine 85
Lawrence 78
Altamura 73
Nanchang 72
Shenyang 72
Jakarta 56
Andover 51
Chicago 48
Falls Church 43
Toronto 43
Hangzhou 41
Rome 41
Pune 40
Fremont 39
Jinan 39
Ottawa 39
San Diego 38
Carate Brianza 35
Helsinki 35
Jiaxing 35
Kunming 34
Brussels 32
Los Angeles 30
Tianjin 30
Zhengzhou 30
Changsha 29
Hebei 29
Melzo 27
Nürnberg 27
Grafing 26
Norwalk 26
Sacramento 24
Bergamo 22
Florence 22
London 22
Shangdi 22
Mountain View 20
Ningbo 20
Dallas 19
Edmonton 18
Phoenix 17
Taizhou 17
Tokyo 17
Leawood 16
Codroipo 15
Hefei 15
Lissone 15
Philadelphia 15
Mainz 13
Washington 13
Lappeenranta 12
Pasir Mas 12
Shinjuku 12
Bologna 11
Kiev 11
Paris 11
Wuhan 11
Cagliari 10
Daejeon 10
Romola 10
Sesto San Giovanni 10
Canazei 9
Changchun 9
Fuzhou 9
Catania 8
Huizen 8
Melbourne 8
Munich 8
Desio 7
San Mateo 7
Yongin-si 7
Auckland 6
Brno 6
Como 6
Totale 15.269
Salva come PNG Salva come JPEG
Nome #
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 302
Age-related changes in the function and structure of the peripheral sensory pathway in mice 296
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 296
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 291
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 280
Studio della neurotossicità periferica indotta da farmaci antitubulinici in modelli sperimentali in vitro e in vivo 265
Artificial apolipoprotein corona enables nanoparticle brain targeting 265
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 263
Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders 249
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 244
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 239
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 235
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 217
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 208
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 207
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 204
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 199
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 197
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 196
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 195
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 188
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 185
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 185
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 184
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 183
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 183
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 181
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 180
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 177
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 177
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 175
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system 174
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 173
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 172
OCT2 transporter involvement in development of cisplatin toxicity 171
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 170
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 169
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 167
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 167
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 167
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: An in vitro study 165
Facial emotion recognition in schizophrenia: An exploratory study on the role of comorbid alcohol and substance use disorders and COMT Val158Met 164
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 163
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 162
MSCs ameliorate clinical course in rats with experimental autoimmune encephalomyelitis 162
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 161
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 159
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 158
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 158
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 158
Lipoplatin tm: a less neurotoxic formulation of cisplatin 158
Current view in platinum drug mechanisms of peripheral neurotoxicity 157
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 156
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 154
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 153
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 151
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 151
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 151
Granulocytes in actively induced Lewis rat EAE 150
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 149
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 143
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 139
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 139
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 137
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 137
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 137
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 135
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 135
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 133
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 133
Epothilone B-induced toxic effects on peripheral nervous system: in vitro and in vivo experimental models 131
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 131
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 130
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 130
Multimodal experimental approach to the study of human neurological diseases 129
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 128
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 128
MSCs effect on Dark Agouti rats affected by chronic EAE 127
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 127
Evaluation of microtubule polimerization involved in the development of bortezomib-induced peripheral neuropathy through new in vitro and in vivo models 127
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 127
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 127
Oxaliplatin induces pH acidification in dorsal root ganglia neurons 127
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 126
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 126
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 126
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 125
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 125
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? 125
Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve 124
Genetic factors influencing the development of vincristine-induced neurotoxicity 124
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 123
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 122
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 122
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 120
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 119
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 119
Characterization of proteasome inhibition and tubulin stabilization in an in vivo rat model of bortezomib-induced peripheral neuropathy 116
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 116
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 115
Totale 16.626
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.594
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.589 0 0 0 0 338 455 593 248 334 319 247 55
2020/20213.424 147 132 377 353 262 306 408 321 290 258 204 366
2021/20221.946 152 234 171 177 139 181 95 106 82 143 134 332
2022/20233.484 389 846 380 332 259 540 63 181 277 51 104 62
2023/20242.986 97 98 101 146 386 725 508 163 158 68 68 468
2024/20252.972 452 898 712 367 543 0 0 0 0 0 0 0
Totale 22.892